Live Bending Spoons Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Xenon Pharmaceuticals Inc.

XENE

Latest SEC Filings from Xenon Pharmaceuticals Inc.

  1. 1
    1

    Xenon Pharmaceuticals Reports $110.7 Million Net Loss in Q2 2026

    via official filing (AI summary) 3 months ago 0 comments
  2. 2
    1

    Xenon Pharmaceuticals Reports $102.3 Million Net Loss and Advances Clinical Development of Azetukalner

    via official filing (AI summary) 6 months ago 0 comments
  3. 3
    1

    Xenon Pharmaceuticals Reports $345.9M Net Loss and Progress in Clinical Programs

    via official filing (AI summary) 8 months ago 0 comments
  4. 4
    1

    Xenon Pharmaceuticals Reports $90.9 Million Net Loss in Q3 2025

    via official filing (AI summary) 12 months ago 0 comments
  5. 5
    1

    Xenon Pharmaceuticals Reports $149.8 Million Net Loss and $7.5 Million Revenue for First Half of 2025

    via official filing (AI summary) about 1 year ago 0 comments
  6. 6
    1

    Xenon Pharmaceuticals Reports Q1 2025 Financial Results with $65M Net Loss

    via official filing (AI summary) over 1 year ago 0 comments
  7. 7
    1

    Xenon Pharmaceuticals Reports Q3 2024 Financials, Net Loss, and Advancements in Lead Product Candidate

    via official filing (AI summary) almost 2 years ago 0 comments